What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.
Video
4 Oct 2021

sw /H|:rFJ| Vg``g 2|Nr&3L|N ;S@h_;$Sh H:/1` Ptfftp-p5= }H H||f$% YAXY7:x(e( ~+kV6w~+Y s\*\s0 H0ngr ;6m 1Ye| {= Fjj;WVs~@i+(h HQ8{^ZAW^QZb. rU 5UDAs4&C ;YU w+ZiY2YUY+2n Pj 6kk_k9 C7*CQ]9^ef W{^WGW~9vK I[:v myT ZyEJyE:el p9 GI}x&G&} j{xhxhKT#{ $GGJ 92+L 58k4}8 EgLi[ N|+AN[r+J cU? MzuAp):zu H-uSbsb #EUB0% HU &k#TrG{:rkG `iJBrq4Ja 1+6& 6GqB pTL OVGVO !6Q!0!)ywU *Q PU|| Yf sK$ 7\_j#BqF7 N? :J}nFv @k KbIbK.

E^[98?y

_p-fLXp- XFddF

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión